India hasn't accepted UK ‘data exclusivity’ demand in FTA to protect generic drug firms

India has not accepted the demand of the UK for inclusion of a ‘data exclusivity’ provision in the free trade agreement, announced on May 6, in a bid to protect the interests of the domestic generic drugs industry, an official said.

- Agencies

During the negotiations, the UK had asked to include this provision in the trade pact. “But India has not accepted that. There is no fear for the Indian generic industry from this agreement. In fact, it is our very important objective to see that the generic drug industry flourishes,” the official said. The sector plays a key role in India’s exports, which are also growing.